Market by Product, Application, Industry Verticals, and Country | Forecast 2021-2028
As
assessed in Triton’s report, the CRISPR market in the Middle East and Africa is
set to register growth based on revenue at a CAGR of 20.51% over the projected
phase 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries considered for analysis in this market are:
• The United Arab Emirates
• Turkey
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
In
the Middle East and Africa, the public healthcare and agriculture sectors are
estimated to benefit significantly from CRISPR, owing to the high prevalence of
tropical diseases and pests. Moreover, the gene drives and other potential
applications make CRISPR ideal for treating various genetic disorders in
Africa, such as sickle-cell anemia. Further, recently, the region witnessed a
massive drop in the number of crops due to high temperatures. As a result,
scientists and plant breeders are developing new crop varieties that are high
yielding and resistant to abiotic and biotic stresses like drought and insects,
respectively. Thus, all these factors will drive the region’s CRISPR market’s
growth.
Among
the major countries, the UAE ranks sixth globally based on congenital
disabilities caused mainly by genetic conditions. Moreover, several inherited
diseases have been identified among the country’s population. Here, most of the
genetic mutations have been clarified, helping develop accurate diagnostic
tools and prevention strategies. Furthermore, researchers in the country have
deployed gene-editing technology CRISPR-Cas9 to understand disease mechanisms
that may offer new ways to develop novel therapies. Other than this,
researchers have worked on familial hypercholesterolemia and disequilibrium
syndrome, extending research in other genetic conditions. Hence, R&D
activities are expected to propel the CRISPR market on a growth path across the
UAE.
Editas
Medicine is a transformative genome editing company involved in treating
genetically defined diseases by correcting disease-causing genes. It operates
across developing and commercializing genome editing technology segments.
Besides, the company is developing a genome editing platform based on clustered
and regularly interspaced palindromic repeats technology. It also serves
clients in the Middle East and Africa region.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA CRISPR MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON CRISPR MARKET
2.2. KEY INSIGHTS
2.2.1. INDUSTRIAL
BIOTECH IS THE FASTEST GROWING INDUSTRY VERTICAL
2.2.2. REWRITING
OF GENETIC DISORDERS THROUGH GENOME SURGERY
2.2.3. INCREASING
USAGE OF PROSPECTIVE APPLICATIONS OF CRISPR TECHNOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. PATENT
OUTLOOK
2.7. FUNDING
OUTLOOK
2.8. KEY
IMPACT ANALYSIS
2.8.1. COST
2.8.2. ACCURACY
2.8.3. EASY
TO USE
2.9. KEY
MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES
2.9.3. CONTRACTS
& PARTNERSHIPS
2.9.4. BUSINESS
EXPANSIONS & DIVESTITURES
2.10. MARKET
DRIVERS
2.10.1. GROWING
LIFESTYLE-ORIENTED DISEASES
2.10.2. SURGING
PREVALENCE OF GENETIC DISEASES
2.11. MARKET
CHALLENGES
2.11.1. GROWING
ETHICAL ISSUES REGARDING TECHNOLOGY USE
2.11.2. LIKELY
MISUSE OF GENE-EDITING TOOL
2.11.3. ABSENCE
OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
2.12. MARKET
OPPORTUNITIES
2.12.1. ADVANCEMENTS
IN GENE-BASED THERAPY IN THE AGRICULTURAL SECTOR
2.12.2. INCREASED
NEED FOR CLINICAL TRIALS
2.12.3. RISE
IN AWARENESS ABOUT GENE THERAPEUTICS
3. MIDDLE
EAST AND AFRICA CRISPR MARKET OUTLOOK - BY PRODUCT
3.1. PLASMIDS
3.2. VECTORS
3.3. PROTEINS
3.4. DESIGNING
TOOLS
3.5. GRNA
3.6. CONTROL
KITS
3.7. LIBRARY
3.8. OTHER
PRODUCTS
4. MIDDLE
EAST AND AFRICA CRISPR MARKET OUTLOOK - BY APPLICATION
4.1. GENOME
EDITING/GENETIC ENGINEERING
4.2. CRISPR
PLASMID
4.3. HUMAN
STEM CELLS
4.4. GRNA DATABASE/GENE
LIBRARY
4.5. CELL
LINE ENGINEERING
5. MIDDLE
EAST AND AFRICA CRISPR MARKET OUTLOOK - BY INDUSTRY VERTICALS
5.1. THERAPEUTICS
AND DRUG DISCOVERY
5.2. BIOLOGICAL
RESEARCH
5.3. AGRICULTURAL
BIOTECH
5.4. INDUSTRIAL
BIOTECH
6. MIDDLE
EAST AND AFRICA CRISPR MARKET – REGIONAL OUTLOOK
6.1. UNITED
ARAB EMIRATES
6.2. SAUDI
ARABIA
6.3. TURKEY
6.4. SOUTH
AFRICA
6.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. ADDGENE
7.2. CARIBOU
BIOSCIENCES INC
7.3. CELLECTIS
BIORESEARCH SAS
7.4. CRISPR
THERAPEUTICS AG
7.5. EDITAS
MEDICINE
7.6. GENSCRIPT
7.7. HORIZON
DISCOVERY GROUP
7.8. INTEGRATED
DNA TECHNOLOGIES
7.9. INTELLIA
THERAPEUTICS
7.10. LONZA
GROUP LTD
7.11. NEW
ENGLAND BIOLABS
7.12. NOVARTIS
INTERNATIONAL AG
7.13. ORIGENE
TECHNOLOGIES INC
7.14. PRECISION
BIOSCIENCES
7.15. SYNTHEGO
CORPORATION
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: FUNDING OUTLOOK OF
PUBLIC COMPANIES
TABLE 4: FUNDING OUTLOOK OF
PRIVATE COMPANIES
TABLE 5: FUNDING OUTLOOK OF
GOVERNMENT ORGANIZATIONS
TABLE 6: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 7: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: FUNDING SCENARIO
SHARE, BY TYPE OF COMPANIES/ORGANIZATION
FIGURE 3: KEY IMPACT ANALYSIS
FIGURE 4: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 5: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY GRNA, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 14: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $
MILLION)
FIGURE 15: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 20: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2021-2028 (IN $
MILLION)
FIGURE 21: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 22: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 23: MIDDLE EAST AND
AFRICA CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 24: MIDDLE EAST AND
AFRICA CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 25: UNITED ARAB
EMIRATES CRISPR MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: SAUDI ARABIA CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: TURKEY CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: SOUTH AFRICA CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: REST OF MIDDLE EAST
& AFRICA CRISPR MARKET 2021-2028 (IN $ MILLION)